Resistance to ICIs in non–small-cell lung cancer is mediated by several mechanisms, which can occur either as distinct events (ie, specific gene mutations) or related to each other (ie, tumor ...
Up to $1 million per project available for research that delivers real-world impact for patients. WASHINGTON, Jan. 15, 2026 /PRNewswire/ -- LUNGevity Foundation, the nation's leading lung ...